DALLAS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions including healthcare workforce technology, today announced the launch of ShiftWise Flex, a next-generation vendor management system (VMS) that leverages state-of-the-art features and automation to empower healthcare organizations with the ability to create a financially sustainable and agile workforce to deliver on their healthcare mission.
As the first healthcare-focused VMS to enter the market in 2002, ShiftWise is the trusted industry leading staffing technology used by many of the nation’s largest and most robust healthcare systems. ShiftWise Flex, AMN Healthcare’s next- generation enhanced product, is the only vendor neutral platform that automates and streamlines the contingent labor management process for nursing, allied health, locums and non-clinical professionals. The platform gives healthcare systems unprecedented flexibility and control over their workforce and ability to meet patient demand.
“We have been working tirelessly to push the boundaries of innovation, and today, we unveil a new era of healthcare workforce technology. With ShiftWise Flex, we have combined our longstanding proven technology with cutting-edge developments and reimagined configuration agility. Healthcare organizations can expect to optimize labor costs, access more talent and build an agile workforce to deliver incredible patient outcomes,” said Nishan Sivathasan, Division President of Workforce Technology at AMN Healthcare.
Key capabilities of ShiftWise Flex include:
For more information about ShiftWise Flex, please visit https://www.amnhealthcare.com/campaign/tech/shiftwise-flex/.
About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the United States. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, permanent placement, executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, language interpretation services, revenue cycle solutions, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools, and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry. For more information about AMN Healthcare, visit www.amnhealthcare.com.
| Media Contact Corporate Communications AMN Healthcare This email address is being protected from spambots. You need JavaScript enabled to view it. | Investor Contact Randle Reece Senior Director, Investor Relations & Strategy AMN Healthcare (866) 861-3229 This email address is being protected from spambots. You need JavaScript enabled to view it. |

| Last Trade: | US$16.37 |
| Daily Change: | 0.10 0.61 |
| Daily Volume: | 1,056,912 |
| Market Cap: | US$628.770M |
November 06, 2025 September 22, 2025 August 07, 2025 June 24, 2025 | |

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load